|
Scoring on ICU admission
|
|
SOFA score
|
6 (3, 7)
|
|
APACHE-II score
|
17 (13, 19)
|
|
SAPS-II score
|
31 (21, 38)
|
|
ICU therapy
|
|
Invasive mechanical ventilation
|
17 (71)
|
|
Days of illness on intubation*, days
|
11 (10, 12)
|
|
Nadir PaO2/FIO2 ratio*
|
169 (108, 183)
|
|
Maximum positive end-expiratory pressure*
|
12 (10, 12)
|
|
Prone positioning*
|
4 (24)
|
|
Neuromuscular blockade*
|
2 (12)
|
|
Extracorporeal membrane oxygenation*
|
1 (6)
|
|
Inhaled nitrate oxide*
|
1 (6)
|
|
Tracheostomy*
|
4 (24)
|
|
Vasopressors
|
15 (63)
|
|
Renal replacement therapy
|
2 (8)
|
|
Enteral feeding within 24 h of ICU admission
|
16 (67)
|
|
Enteral feeding within 48 h of ICU admission
|
19 (79)
|
|
Pharmaceutical Treatments
|
|
Systemic steroids
|
|
High-dose methylprednisolone
|
16 (67)
|
|
Low-dose methylprednisolone
|
5 (21)
|
|
No systemic steroid
|
3 (13)
|
|
Antiviral agents
|
|
Favipiravir
|
9 (38)
|
|
Lopinavir/Ritonavir
|
4 (17)
|
|
Antibacterial agents†
|
|
Piperacillin/Tazobactam and Azithromycin
|
7 (29)
|
|
Piperacillin/Tazobactam and Levofloxacin
|
4 (17)
|
|
Ceftriaxone and Azithromycin
|
10 (42)
|
|
Ceftriaxone and Levofloxacin
|
1 (4)
|
|
Ceftriaxone and Minocycline
|
1 (4)
|
|
Ampicillin/Sulbactam and Azithromycin
|
1 (4)
|
|
Anticoagulants
|
|
Subcutaneous bolus injection of unfractionated heparin
|
6 (25)
|
|
Intravenous continuous unfractionated heparin
|
12 (50)
|
|
No anticoagulant
|
6 (25)
|
